Question 1

What is the catalog number for Hsa-miR-1913 inhibitor?

Accepted Answer

The catalog number for Hsa-miR-1913 inhibitor is HY-RI00370.

Question 2

What sizes are available for Hsa-miR-1913 inhibitor?

Accepted Answer

Hsa-miR-1913 inhibitor is available in the following size(s): 5 nmol, 20 nmol.

Question 3

How many pack sizes does Hsa-miR-1913 inhibitor come in?

Accepted Answer

Hsa-miR-1913 inhibitor is available in 2 different pack sizes.

Question 4

Is Hsa-miR-1913 inhibitor in stock?

Accepted Answer

Hsa-miR-1913 inhibitor is currently made to order / not held in immediate stock. Contact us for lead time.

Question 5

Who manufactures Hsa-miR-1913 inhibitor?

Accepted Answer

Hsa-miR-1913 inhibitor is manufactured by QuantiMol.

Question 6

What is the estimated delivery time for Hsa-miR-1913 inhibitor?

Accepted Answer

Estimated delivery time for Hsa-miR-1913 inhibitor is approximately 15 business day(s), depending on your location.

Question 7

Where can I find the safety data sheet (SDS/MSDS) for Hsa-miR-1913 inhibitor?

Accepted Answer

The safety data sheet for Hsa-miR-1913 inhibitor is available here: http://file.medchemexpress.com/batch_PDF/HY-RI00370/.

Question 8

What is Hsa-miR-1913 inhibitor used for?

Accepted Answer

Hsa-miR-1913 inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes

Question 9

Do you offer custom or private-label production of this type of product?

Accepted Answer

Yes, custom antibody development and private-label production services are available. Contact our sales team to discuss your target, timeline, and quantity requirements.

Question 10

What is the immunogen used to generate this antibody?

Accepted Answer

Immunogen or antigen details used to raise this antibody are listed on the product datasheet under immunogen information.

Question 11

What is the recommended positive control for this assay?

Accepted Answer

A recommended positive control, where one is specified by the manufacturer, is listed on the datasheet or in the assay protocol.

Hsa-miR-1913 inhibitor

Product Specifications

UNSPSC

Target

Type

Related Pathways

Field of Research

Assay Protocol

Solubility

Molecular Weight

Shipping Conditions

Scientific Category

Clinical Information

Available Sizes

Frequently Asked Questions

Explore Other Products

Human POLR2A siRNA

Human POLR2A siRNA

IRG1 CRISPR Activation Plasmid (h2)

AFP antibody

Estrogen Receptor Beta (ESR2) Antibody (AF488)

Estrogen Receptor Beta (ESR2) Antibody (AF488)